Target intelligence / Profile preview

Cytochrome b subunit (Cytochrome b)

Target
Cytochrome b
Molecular classification
Enzyme, Electron transport chain protein, Mitochondrial membrane protein, Component of Complex III (bc1 complex), Cytochrome
01

Overview

Cytochrome b subunit is an integral membrane protein that is the key component of the cytochrome bc1 complex (Complex III) in the mitochondrial electron transport chain of eukaryotes and in the corresponding complexes of prokaryotes and photosynthetic organisms[2][8][1]. It contains eight transmembrane helices and coordinates two non-covalently bound heme groups crucial for electron transfer[1][2][3]. The cytochrome b subunit couples the transfer of electrons from ubiquinol to cytochrome c with proton translocation across the mitochondrial membrane, helping generate the proton gradient necessary for ATP production[2][6][8]. Inhibitors of the cytochrome b subunit disrupt cellular ATP synthesis and are therapeutically important as antimicrobials or antifungals (e.g., atovaquone, azoxystrobin)[2][5]. Mutations in its gene are linked to mitochondrial diseases and also serve as markers for drug resistance in pathogens. The structure and function of cytochrome b are highly conserved, though the chloroplast homolog (cytochrome b6) participates in the photosynthetic electron transport chain[1][4].

Other names
Cytochrome bCytochrome b-c1 complex subunit 1Cytochrome bc1 complex cytochrome b subunitubiquinol-cytochrome c reductase cytochrome b subunitmitochondrial cytochrome bcytochrome b6 (chloroplast homolog)
02

Mechanism of action

Inhibition of electron transfer in the bc1 complex; Disruption of proton motive force and ATP generation; Induction of oxidative stress by impaired electron flow

03

Biological functions

Electron transportATP synthesisProton translocationCellular respirationOxidation-reduction (redox) reactions
04

Disease associations

Mitochondrial diseaseCardiovascular diseaseMyopathiesNeurodegenerative diseaseDrug resistance in infectious diseases (notably mycobacterial infections)
05

Safety considerations

Mitochondrial toxicity (potential in drugs targeting eukaryotic cytochrome b)Off-target effects in human tissues, especially for broad inhibitorsDrug resistance development in pathogens
06

Interacting drugs

Atovaquone (antimalarial)

4 more in the full profile.

07

Biomarkers

Mutations in the cytochrome b gene (mitochondrial DNA) for diagnosing mitochondrial disordersDrug resistance markers in pathogens (e.g., Plasmodium falciparum, Mycobacterium tuberculosis)

Beyond the preview

Go deeper on Cytochrome b subunit (Cytochrome b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b subunit (Cytochrome b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call